We are live on ! Find out more
TARS icon

Tarsus Pharmaceuticals
TARS

40 hedge funds and large institutions have $523M invested in Tarsus Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

62.79% more ownership

Funds ownership: 0% → 62.79% (+63%)

Holders
40
Holders Change
+40
Holders Change %
–
% of All Funds
0.71%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
40
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
+$92.4M
2
RI
RTW Investments
New York
+$70.2M
3
FM
Frazier Management
Washington
+$54.6M
4
CAM
Cormorant Asset Management
Massachusetts
+$48.8M
5
PA
Perceptive Advisors
New York
+$36.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VC
1
Vivo Capital
California
$134M +$92.4M +3,245,035 New
RI
2
RTW Investments
New York
$99M +$70.2M +2,463,601 New
FM
3
Frazier Management
Washington
$79.2M +$54.6M +1,917,157 New
CAM
4
Cormorant Asset Management
Massachusetts
$70M +$48.8M +1,714,269 New
PA
5
Perceptive Advisors
New York
$53.6M +$36.9M +1,296,416 New
TCM
6
TimesSquare Capital Management
New York
$19.2M +$13.2M +464,600 New
BlackRock
7
BlackRock
New York
$13.3M +$9.18M +322,423 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$11.2M +$7.72M +270,891 New
Sands Capital Management
9
Sands Capital Management
Virginia
$10.7M +$7.41M +260,000 New
Ensign Peak Advisors
10
Ensign Peak Advisors
Utah
$8.27M +$5.7M +200,000 New
Millennium Management
11
Millennium Management
New York
$5.96M +$4.11M +144,236 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$4.56M +$3.14M +110,375 New
State Street
13
State Street
Massachusetts
$4M +$2.76M +96,884 New
Northern Trust
14
Northern Trust
Illinois
$2.91M +$2.01M +70,399 New
Charles Schwab
15
Charles Schwab
California
$1.54M +$1.06M +37,223 New
CCM
16
CAAS Capital Management
New York
$827K +$570K +20,000 New
Invesco
17
Invesco
Georgia
$801K +$552K +19,367 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$761K +$525K +18,417 New
JP Morgan Chase
19
JP Morgan Chase
New York
$694K +$478K +16,783 New
N
20
Nuveen
North Carolina
$417K +$287K +10,088 New
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$384K +$265K +9,299 New
State of Wisconsin Investment Board
22
State of Wisconsin Investment Board
Wisconsin
$355K +$245K +8,600 New
HPCM
23
Hunter Perkins Capital Management
Illinois
$331K +$228K +8,000 New
Morgan Stanley
24
Morgan Stanley
New York
$263K +$182K +6,372 New
Deutsche Bank
25
Deutsche Bank
Germany
$178K +$123K +4,314 New
1
2

TARS Hedge Fund Activity: Q4 2020 in Review

40 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Tarsus Pharmaceuticals (TARS) for Q4 2020, worth a combined $523M.

Buyers outnumbered sellers: 40 funds opened new TARS positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Vivo Capital, opening a new position worth an estimated $92.4M.

  • 40 institutional investors held Tarsus Pharmaceuticals (TARS) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $523M of Tarsus Pharmaceuticals stock for Q4 2020.
  • 40 funds opened new Tarsus Pharmaceuticals positions in Q4 2020 and 0 closed out, a net change of +40 holders.
  • The largest Tarsus Pharmaceuticals buyer in Q4 2020 was Vivo Capital, an estimated $92.4M added.

Based on aggregated 13F filings for Q4 2020.